NASDAQ:EGRX
Eagle Pharmaceuticals, Inc.
- Stock
Last Close
1.96
01/05 20:00
Market Cap
78.44M
Beta: 0.91
Volume Today
470
Avg: 153.65K
PE Ratio
4.72
PFCF: −7.76
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 8.17M - | 8.89M 8.85% | 3.93M 55.81% | 6.71M 70.83% | 7.43M 10.79% | 7.32M 1.54% | 14.99M 104.79% | 34.85M 132.47% | ||
average payables | 4.00M - | 9.33M 133.18% | 13.35M 43.08% | 10.95M 17.98% | 7.69M 29.77% | 5.87M 23.73% | 11.35M 93.51% | 17.71M 56.06% | ||
average receivables | 16.78M - | 34.23M 103.98% | 48.01M 40.25% | 60.15M 25.30% | 57.24M 4.84% | 49.56M 13.42% | 46.13M 6.92% | 56.79M 23.11% | ||
book value per share | 5.92 - | 9.74 64.34% | 11.86 21.84% | 10.89 8.23% | 13.03 19.67% | 13.80 5.92% | 13.52 2.01% | 18.06 33.56% | ||
capex per share | -0.12 - | -1.33 979.87% | -0.34 74.22% | -0.01 97.38% | -0.06 527.28% | -0.06 1.91% | -0.02 55.33% | -0.01 44.39% | ||
capex to depreciation | -16.79 - | -13.02 22.47% | -1.38 89.37% | -0.04 97.38% | -0.17 360.99% | -0.16 6.18% | -0.09 45.19% | -0.01 82.77% | ||
capex to operating cash flow | 0.19 - | -0.39 300.90% | -0.09 77.36% | -0.00 97.12% | -0.01 446.62% | -0.02 8.74% | -0.01 24.16% | -0.00 69.33% | ||
capex to revenue | -0.03 - | -0.11 284.45% | -0.02 79.94% | -0.00 97.15% | -0.00 536.16% | -0.00 0.28% | -0.00 52.66% | -0.00 70.14% | ||
cash per share | 5.19 - | 3.40 34.43% | 7.59 123.26% | 5.34 29.73% | 7.98 49.60% | 7.65 4.13% | 7.48 2.21% | 4.28 42.84% | ||
days of inventory on hand | 350.89 - | 18.08 94.85% | 32.67 80.71% | 48.95 49.86% | 39.35 19.61% | 64.83 64.73% | 189.58 192.44% | 183.75 3.07% | ||
days payables outstanding | 91.98 - | 97.12 5.59% | 76.47 21.26% | 58.46 23.55% | 32.74 44.00% | 50.32 53.71% | 142.18 182.56% | 73.02 48.64% | ||
days sales outstanding | 144.77 - | 81.28 43.86% | 82.99 2.11% | 113.76 37.08% | 89.44 21.38% | 99.35 11.07% | 87.55 11.87% | 83.51 4.62% | ||
debt to assets | -0.00 - | 0.18 - | 0.19 5.19% | 0.15 18.61% | 0.15 3.28% | 0.11 23.30% | 0.15 36.87% | |||
debt to equity | -0.00 - | 0.27 - | 0.28 3.56% | 0.22 22.09% | 0.20 7.33% | 0.16 18.98% | 0.27 65.52% | |||
dividend yield | ||||||||||
earnings yield | 0.00 - | 0.07 3,376.08% | 0.06 2.59% | 0.05 16.72% | 0.02 67.70% | 0.02 10.25% | -0.01 167.98% | 0.09 826.24% | ||
enterprise value | 1.27B - | 1.18B 7.35% | 739.92M 37.27% | 560.64M 24.23% | 755.15M 34.69% | 561.77M 25.61% | 592.51M 5.47% | 385.20M 34.99% | ||
enterprise value over ebitda | 492.51 - | 22.82 95.37% | 9.33 59.14% | 11.15 19.52% | 25.74 130.94% | 18.71 27.31% | 699.54 3,638.19% | 5.88 99.16% | ||
ev to operating cash flow | -131.01 - | 22.17 116.92% | 12.56 43.36% | 10.70 14.78% | 13.49 26.03% | 11.35 15.86% | 21.00 85.00% | 7.60 63.82% | ||
ev to sales | 19.22 - | 6.23 67.62% | 3.13 49.79% | 2.63 15.92% | 3.85 46.67% | 2.99 22.40% | 3.45 15.47% | 1.22 64.78% | ||
free cash flow per share | -0.76 - | 2.09 375.23% | 3.56 69.96% | 3.54 0.56% | 4.01 13.45% | 3.62 9.91% | 2.14 40.89% | 3.91 82.75% | ||
free cash flow yield | -0.01 - | 0.03 407.59% | 0.07 152.43% | 0.09 31.85% | 0.07 23.92% | 0.08 16.22% | 0.04 45.94% | 0.13 218.36% | ||
graham net net | 4.72 - | 1.51 67.99% | 4.41 191.89% | 3.72 15.68% | 5.36 43.93% | 5.81 8.49% | 4.77 18.00% | -3.02 163.36% | ||
graham number | 4.74 - | 33.89 614.94% | 30.30 10.61% | 23.00 24.08% | 17.46 24.07% | 16.62 4.86% | 14.18 14.66% | 33.46 135.97% | ||
income quality | -3.78 - | 0.65 117.28% | 1.13 73.65% | 1.64 44.76% | 3.91 138.22% | 4.13 5.55% | -3.27 179.23% | 1.42 143.49% | -11.55 912.07% | |
intangibles to total assets | 0 - | 0.34 Infinity% | 0.23 31.08% | 0.24 3.82% | 0.22 10.35% | 0.21 4.31% | 0.20 4.47% | 0.40 102.43% | 0 100% | |
interest coverage | 232.73 - | 6.67K 2,765.53% | 65.13 99.02% | 13.38 79.45% | 8.12 39.31% | 9.80 20.66% | -1.78 118.18% | 13.21 841.72% | ||
interest debt per share | -0.00 - | 0.00 110.47% | 3.24 628,790.84% | 3.19 1.45% | 3.00 6.06% | 2.94 1.86% | 2.31 21.50% | 5.14 122.63% | ||
inventory turnover | 1.04 - | 20.19 1,841.13% | 11.17 44.66% | 7.46 33.27% | 9.27 24.39% | 5.63 39.29% | 1.93 65.80% | 1.99 3.17% | ||
invested capital | -0.00 - | 0.27 - | 0.28 3.56% | 0.22 22.09% | 0.20 7.33% | 0.16 18.98% | 0.27 65.52% | |||
market cap | 1.35B - | 1.23B 8.86% | 806.80M 34.54% | 595.03M 26.25% | 826.37M 38.88% | 627.83M 24.03% | 664.56M 5.85% | 378.06M 43.11% | ||
net current asset value | 88.00M - | 46.77M 46.85% | 97.78M 109.09% | 86.00M 12.05% | 104.07M 21.01% | 98.89M 4.98% | 95.33M 3.60% | 16.15M 83.05% | ||
net debt to ebitda | -30.59 - | -1.02 96.66% | -0.84 17.52% | -0.68 18.90% | -2.43 255.10% | -2.20 9.36% | -85.07 3,765.70% | 0.11 100.13% | ||
net income per share | 0.17 - | 5.24 3,010.32% | 3.44 34.41% | 2.16 37.19% | 1.04 51.83% | 0.89 14.54% | -0.66 174.33% | 2.76 516.89% | ||
operating cash flow per share | -0.64 - | 3.43 637.52% | 3.90 13.89% | 3.55 9.08% | 4.07 14.76% | 3.67 9.80% | 2.16 41.11% | 3.92 81.30% | ||
payables turnover | 3.97 - | 3.76 5.29% | 4.77 27.00% | 6.24 30.81% | 11.15 78.58% | 7.25 34.94% | 2.57 64.61% | 5.00 94.71% | ||
receivables turnover | 2.52 - | 4.49 78.11% | 4.40 2.06% | 3.21 27.05% | 4.08 27.19% | 3.67 9.97% | 4.17 13.47% | 4.37 4.84% | ||
research and ddevelopement to revenue | 0.42 - | 0.16 62.03% | 0.14 13.75% | 0.21 51.17% | 0.19 9.76% | 0.16 12.77% | 0.30 82.34% | 0.11 63.98% | ||
return on tangible assets | 0.02 - | 0.58 2,695.70% | 0.25 56.50% | 0.18 29.67% | 0.07 59.30% | 0.06 16.78% | -0.04 170.97% | 0.15 445.96% | ||
revenue per share | 4.34 - | 12.20 180.89% | 15.67 28.49% | 14.44 7.84% | 14.24 1.40% | 13.93 2.19% | 13.14 5.64% | 24.48 86.24% | ||
roe | 0.03 - | 0.54 1,792.66% | 0.29 46.17% | 0.20 31.56% | 0.08 59.75% | 0.06 19.32% | -0.05 175.86% | 0.15 412.13% | ||
roic | 0.03 - | 0.54 1,798.50% | 0.23 56.83% | 0.17 27.95% | 0.06 61.56% | 0.06 8.56% | -0.03 144.92% | 0.10 494.55% | ||
sales general and administrative to revenue | 0.31 - | |||||||||
shareholders equity per share | 5.92 - | 9.74 64.34% | 11.86 21.84% | 10.89 8.23% | 13.03 19.67% | 13.80 5.92% | 13.52 2.01% | 18.06 33.56% | ||
stock based compensation to revenue | 0.06 - | 0.05 15.72% | 0.07 26.44% | 0.09 37.24% | 0.11 25.53% | 0.13 17.39% | 0.11 13.52% | 0.05 54.42% | ||
tangible asset value | 90.34M - | 78.86M 12.71% | 116.08M 47.19% | 102.92M 11.34% | 123.85M 20.34% | 133.35M 7.67% | 126.04M 5.48% | 70.20M 44.30% | ||
tangible book value per share | 5.92 - | 5.08 14.30% | 7.69 51.39% | 6.97 9.33% | 9.00 29.21% | 9.89 9.85% | 9.66 2.37% | 5.43 43.80% | ||
working capital | 88.00M - | 68.89M 21.71% | 141.40M 105.23% | 124.16M 12.19% | 140.63M 13.26% | 127.98M 8.99% | 98.23M 23.25% | 77.67M 20.93% |
All numbers in USD (except ratios and percentages)